Search

Displaying results 6671 - 6680 of 10000 in total
  1. Drug

    Quilseconazole

    go.drugbank.com/drugs/DB17758
    Experimental

    Synonyms: 2-pyridineethanol, .alpha.-(2,4-difluorophenyl)-.beta.,.beta.-difluoro-.alpha.-(1h-tetrazol-1-ylmethyl)-5-(4-(trifluoromethoxy)phenyl)-, (.alpha.r)-Categories: Heterocyclic Compounds, 1-Ring
  2. Drug

    Respigam

    go.drugbank.com/drugs/DB17765
    Investigational

    Categories: Immunoglobulin G
  3. Drug

    EF-022

    go.drugbank.com/drugs/DB17768
    Investigational

    EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.

    Synonyms: Modified vitamin D binding protein, Modified Vitamin D Binding Protein Macrophage Activator
  4. Drug

    Octovalent O-polysaccharide-toxin A conjugate vaccine

    go.drugbank.com/drugs/DB17789
    Experimental

    Octovalent O-polysaccharide-toxin A conjugate vaccine is currently being investigated to treat Pseudomonas Aeruginosa infection in patients with cystic fibrosis.[A259462]

    Synonyms: Octovalent O-polysaccharide-toxin A conjugate vaccine, octavalent Psuedomonas aeruginosa O-polysaccaharide-toxin A conjugate
  5. Drug

    N-9-Methoxynonyldeoxynojirimycin

    go.drugbank.com/drugs/DB17804
    Experimental

    Salts: N-9-Methoxynonyldeoxynojirimycin hydrochlorideCategories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Apc001

    go.drugbank.com/drugs/DB17819
    Experimental

    Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta.

  7. Drug

    Ultevursen

    go.drugbank.com/drugs/DB17835
    Investigational

    Ultevursen is a single-stranded RNA-based oligonucleotide targeting exon 13 of the USH2A gene that encodes usherin. … It was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa.

  8. Drug

    AGA2115

    go.drugbank.com/drugs/DB17840
    Investigational

    AGA2115 is a humanized bispecific antibody neutralizing both sclerostin and Dickkopf-1. … Developed by Angitia Biopharmaceuticals, AGA2115 is being investigated for the treatment of osteogenesis imperfect.[L46646]

  9. Drug

    CDX-6512

    go.drugbank.com/drugs/DB17841
    Experimental

    CDX-6512 is a modified, gastrointestinal-stable bacterial leucine decarboxylase. Developed by Codexis, it is being investigated for the treatment of homocystinuria And Maple Syrup Urine Disease.

  10. Drug

    Sonpiretigene isteparvovec

    go.drugbank.com/drugs/DB17844
    Investigational

    Sonpiretigene isteparvovec is an ambient-light activatable Multi-Characteristic Opsin (MCO) optogenetic therapy. … Developed by Nanoscope Therapeutics, it is being investigated for vision restoration in advanced retinitis pigmentosa (RP).

    Synonyms: VMCO-1, vMCO-I